1/21
09:41 am
nams
Rating for NAMS
Medium
Report
Rating for NAMS
1/21
09:41 am
nams
Rating for NAMS
Medium
Report
Rating for NAMS
1/21
07:17 am
nams
NewAmsterdam Pharma (NASDAQ:NAMS) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Medium
Report
NewAmsterdam Pharma (NASDAQ:NAMS) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
1/21
07:17 am
nams
NewAmsterdam Pharma (NASDAQ:NAMS) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Medium
Report
NewAmsterdam Pharma (NASDAQ:NAMS) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
1/6
07:17 am
nams
NewAmsterdam Pharma (NASDAQ:NAMS) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
Low
Report
NewAmsterdam Pharma (NASDAQ:NAMS) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
12/16
12:28 pm
nams
Rating for NAMS
Low
Report
Rating for NAMS
12/2
01:14 pm
nams
Rating for NAMS
Low
Report
Rating for NAMS
12/2
01:14 pm
nams
Rating for NAMS
Low
Report
Rating for NAMS
12/2
01:14 pm
nams
Rating for NAMS
Low
Report
Rating for NAMS
11/6
11:21 am
nams
Rating for NAMS
Low
Report
Rating for NAMS
11/6
11:21 am
nams
Rating for NAMS
Low
Report
Rating for NAMS
11/5
01:10 pm
nams
Rating for NAMS
Medium
Report
Rating for NAMS
11/5
01:10 pm
nams
Rating for NAMS
Medium
Report
Rating for NAMS